Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 375.00
Bid: 376.00
Ask: 389.00
Change: -7.00 (-1.83%)
Spread: 13.00 (3.457%)
Open: 375.00
High: 375.00
Low: 375.00
Prev. Close: 382.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of the 2020 Annual General Meeting

8 Jun 2020 14:06

RNS Number : 2926P
Zotefoams PLC
08 June 2020
 

Zotefoams plc

 

Result of the 2020 Annual General Meeting

 

The 2020 Annual General Meeting of Zotefoams plc was held at the offices of Zotefoams plc, 675 Mitcham Road, Croydon CR9 3AL on 8 June 2020.

 

Proxy votes were received from shareholders in respect of 22,890,906 ordinary shares amounting to 47.1% of the issued share capital. The total number of ordinary shares in issue in relation to the AGM is 48,621,234.

 

All resolutions put to the meeting were passed on a show of hands. The proxy votes cast in respect of the resolutions received prior to the meeting were as follows:

 

Resolution

For

Against

Discretion

Votes Withheld

1.

To receive the Annual Report of the Company for the year ended 31 December 2019.

22,875,128

4,078

11,699

 

0

2.

To approve the New Directors' Remuneration Policy.

20,542,091

2,331,595

12,699

4,520

3.

To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2019.

22,866,741

 

9,931

12,699

 

1,384

4.

To elect A M Fielding as a Director.

22,879,207

 

0

11,699

 

0

5.

To elect C.A Wall as a Director

.

22,879,207

0

11,699

0

6.

To re-elect S P Good as a Director.

21,999,130

876,940

 

11,699

 

3,136

7.

To re-elect D B Stirling as a Director.

22,876,093

3,114

 

11,699

 

0

8.

To re-elect G C McGrath as a Director.

22,876,093

 

3,114

 

11,699

 

0

9.

To re-elect D G Robertson as a Director.

22,876,071

 

0

 

11,699

3,136

10.

To re-elect J D Carling as a Director.

22,879,207

 

0

 

11,699

 

0

11.

To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company.

22,758,354

 

853

11,699

 

120,000

 

12.

To authorise the Audit Committee to determine the Auditors' remuneration.

22,878,354

 

853

11,699

 

0

 

13.

To authorise the Directors to allot shares.

22,678,500

 

195,685

 

13,585

 

3,136

 

14.

To authorise the Directors to allot equity securities for cash.

22,747,057

 

132,150

 

11,699

 

0

 

15.

To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) purposes only.

22,742,978

 

136,228

 

11,699

 

0

 

16.

To authorise market purchases of shares.

22,874,816

 

4,390

 

11,699

 

0

 

17.

That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

22,588,685

 

290,522

 

11,699

 

0

 

Resolutions 1 to 13 inclusive were passed as ordinary resolutions and resolutions 14 to 17 inclusive were passed as special resolutions.

 

Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2020 Annual General Meeting which is at the rear of the 2019 Annual Report and which is also available on the Company's website.

 

Lydia Harratt

Group Company Secretary

8 June 2020

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGXVLFBBQLBBBZ
Date   Source Headline
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20248:36 amRNSReplacement Notice Transactions Of Directors/PDMRs
26th Mar 20247:00 amRNSGroup CEO succession
25th Mar 20245:58 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd Mar 20245:31 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSPreliminary Results
12th Mar 20241:41 pmRNSNotification Of Transactions Of Directors/PDMRs
14th Feb 20247:00 amRNSZotefoams joins independent authority, RECOUP
13th Feb 202412:31 pmRNSNotification Of Transactions Of Directors/PDMRs
7th Feb 20247:00 amRNSNotice of results and investor presentation
5th Feb 20241:20 pmRNSHolding(s) in Company
22nd Jan 20241:58 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSFull Year Trading Update
12th Jan 20245:13 pmRNSDirector/PDMR Shareholding
12th Jan 202412:28 pmRNSNotification Of Transactions Of Directors/PDMRs
5th Jan 202412:47 pmRNSReplacement Holding(s) in Company
4th Jan 20243:24 pmRNSHolding(s) in Company
4th Jan 20241:17 pmRNSHolding(s) in Company
13th Dec 20234:49 pmRNSHolding(s) in Company
13th Dec 20234:31 pmRNSReplacement Notice Transactions Of Directors/PDMRs
13th Dec 20231:54 pmRNSHolding(s) in Company
12th Dec 20233:46 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Dec 202312:45 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Dec 20231:53 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Nov 20237:00 amRNSTop industry award for ReZorce® beverage cartons
14th Nov 202311:56 amRNSNotification Of Transactions Of Directors/PDMRs
8th Nov 20235:38 pmRNSHolding(s) in Company
7th Nov 20237:01 amRNSGroup CEO succession
7th Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSZotefoams programme extension at Nike
12th Oct 202312:09 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20239:47 amRNSNotification Of Transactions Of Directors/PDMRs
29th Sep 20237:00 amRNSBoard Changes
18th Sep 20234:45 pmRNSHolding(s) in Company
12th Sep 202310:57 amRNSNotification Of Transactions Of Directors/PDMRs
5th Sep 20234:07 pmRNSHolding(s) in Company
31st Aug 20233:14 pmRNSHolding(s) in Company
29th Aug 20237:00 amRNSInvestor presentation on Investor Meet Company
25th Aug 20237:00 amRNSIssue of Equity
14th Aug 20231:51 pmRNSNotification of Transactions of Directors/PDMRs
9th Aug 20233:29 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSInterim Results
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.